Abstract:Abstract Purpose Stem cell-based attempts at regenerating chronically failing heart have not met the clinical outcomes expected by experimental studies. The efficacy of cell transplant is largely dependent on the engraftment rate, which requires cells to receive an adequate blood supply. To address this issue, we propose to develop a composite tissue engineering construct made of biocompatible pre-vascularized fibrin hydrogel. The objectives of this study are to determine co-culture conditions and to optimize fabrication of fibrin hydrogels supporting generation of capillaries and cardiomyocyte activity at the same time. Materials and methods Rat primary cardiomyocytes were co-seeded with human umbilical vein endothelial cells (HUVECs) in fibrin hydrogels. Cultures were performed in 96 well plates. Cells were cultured in a mixture of medium conditioned with human dermal fibroblasts and of cardiomyocyte medium (1:1) for 8 days. To improve co-culture of the two cell types, insulin (1 μg/mL) and/or VEGF (5 ng/mL) were added 24 hours after the initial day of culture and maintained for 24 hours. The cells treated with VEGF were also treated 5 days after initial seeding with insulin and VEGF (insulin at 1 μg/mL and VEGF at 1 or 5 ng/mL). After culture, cardiomyocytes were immuno-stained for Troponin T or Connexin-43, endothelial cells for CD31, basement membrane for collagen IV. From spinning disk images, cardiomyocyte volume, contraction and total length/ branches of capillaries were measured. Results : We first determine the best conditions allowing the generation of active cardiomyocytes and the formation of a network of mature capillaries into fibrin hydrogels. We showed that cardiomyocytes volume and contraction were not influenced by the addition of VEGF or insulin. For cells treated with VEGF for 24 hours, total length and total branches of capillaries were significantly increased over other conditions without supplements (control), or with insulin alone or with VEGF. We also observed lumen formation and basement membrane deposition. Conclusions These results may provide a new model of vascularized human heart tissue for in vitro studies, displaying cardiomyocyte contractility together with lumenized capillary formation. Furthermore, our data may help overcome current obstacles toward the success of cardiac cell therapy for damaged myocardium. In such approach, endothelial capillaries will serve as structural and trophic support through inosculation with the host cardiac vasculature after epicardial graft. As a perspective of this work, and in order to improve the cardiomyocyte alignment and the development of capillaries, we will design specific PDMS mold to allow the formation of a micro-tissue. Application of human cardiac cells and implantation in in vivo model is expected. Acknowledgement/Funding ESC research grant, Fondation de l'avenir, Societe Francaise de Cardiologie, Institut Servier

The Effect of Controlled Expression of Vegf by Transduced Myoblasts in A Cardiac Patch on Vascularization in A Mouse Model of Myocardial Infarction

Cardiac Stromal Cell Patch Integrated With Engineered Microvessels Improves Recovery From Myocardial Infarction In Rats And Pigs

In situ constructive myocardial remodeling of extracellular matrix patch enhanced with controlled growth factor release

Transient secretion of VEGF protein from transplanted hiPSC-CMs enhances engraftment and improves rat heart function post MI

In vivo grafting of large engineered heart tissue patches for cardiac repair

VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells.

VEGF-B Promotes Endocardium-Derived Coronary Vessel Development and Cardiac Regeneration

A Vascularized Conductive Elastic Patch for the Repair of Infarcted Myocardium through Functional Vascular Anastomoses and Electrical Integration

Transplantation Of Novel Vascular Endothelial Growth Factor Gene Delivery System Manipulated Skeletal Myoblasts Promote Myocardial Repair

Long-term functional benefits of epicardial patches as cell carriers

P4499Development of a hydrogel-based pre-vascularized 3D cardiac patch displaying capillary network

A Heartrate-Matched Patch for Mechano-Chemical Treatment of Myocardial Infarction: Optimal Design and Transspecies Application

Vascularization of Engineered Spatially Patterned Myocardial Tissue Derived From Human Pluripotent Stem Cells in vivo

Combining Pharmacological Mobilization with Intramyocardial Delivery of Bone Marrow Cells Over-Expressing VEGF is More Effective for Cardiac Repair.

Biomimetic Approach to Cardiac Tissue Engineering: Oxygen Carriers and Channeled Scaffolds

Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction

Elastomeric cardiopatch scaffold for myocardial repair and ventricular support

FSTL-1 loaded 3D bioprinted vascular patch regenerates the ischemic heart tissue

Advancing Myocardial Infarction Treatment: Harnessing Multi-Layered Recellularized Cardiac Patches with Fetal Myocardial Scaffolds and Acellular Amniotic Membrane

Sustained Delivery of VEGF from Designer Self-Assembling Peptides Improves Cardiac Function after Myocardial Infarction

Stem Cell-Loaded Nanofibrous Patch Promotes the Regeneration of Infarcted Myocardium with Functional Improvement in Rat Model